Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,483 | 107 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $318.99 | 9 | $0 (2019) |
| Janssen Biotech, Inc. | $253.27 | 21 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $177.13 | 8 | $0 (2017) |
| Amgen Inc. | $140.28 | 4 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $119.94 | 5 | $0 (2018) |
| TESARO, Inc. | $115.57 | 2 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $111.08 | 1 | $0 (2017) |
| Celgene Corporation | $103.54 | 3 | $0 (2018) |
| Exelixis Inc. | $94.48 | 2 | $0 (2019) |
| Bayer HealthCare Pharmaceuticals Inc. | $93.61 | 4 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $13.45 | 1 | Pharmacyclics LLC, An AbbVie Company ($13.45) |
| 2019 | $361.62 | 6 | Genentech USA, Inc. ($77.52) |
| 2018 | $355.17 | 10 | TESARO, Inc. ($88.36) |
| 2017 | $1,753 | 90 | Genentech USA, Inc. ($241.47) |
All Payment Transactions
107 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/28/2021 | Pharmacyclics LLC, An AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: ONCOLOGY | ||||||
| 11/19/2019 | Bayer HealthCare Pharmaceuticals Inc. | Vitrakvi (Drug) | Food and Beverage | In-kind items and services | $42.76 | General |
| Category: Oncology | ||||||
| 11/18/2019 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Food and Beverage | In-kind items and services | $41.14 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/23/2019 | Genentech USA, Inc. | TECENTRIQ (Biological) | Food and Beverage | In-kind items and services | $77.52 | General |
| Category: BioOncology | ||||||
| 08/20/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | GILOTRIF (Drug) | Food and Beverage | In-kind items and services | $64.61 | General |
| Category: ONCOLOGY | ||||||
| 07/23/2019 | GENZYME CORPORATION | LIBTAYO (Drug) | Food and Beverage | In-kind items and services | $66.35 | General |
| Category: ONCOLOGY | ||||||
| 02/05/2019 | Exelixis Inc. | Cabometyx (Drug) | Food and Beverage | In-kind items and services | $69.24 | General |
| Category: Oncology | ||||||
| 10/23/2018 | Amgen Inc. | Kyprolis (Biological) | Food and Beverage | In-kind items and services | $62.30 | General |
| Category: Oncology | ||||||
| 09/24/2018 | Janssen Biotech, Inc. | Erleada (Drug), DARZALEX | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: Oncology | ||||||
| 08/21/2018 | E.R. Squibb & Sons, L.L.C. | EMPLICITI (Biological) | Food and Beverage | Cash or cash equivalent | $59.07 | General |
| Category: Oncology | ||||||
| 06/13/2018 | Janssen Biotech, Inc. | ZYTIGA (Drug), Erleada, DARZALEX | Food and Beverage | In-kind items and services | $12.39 | General |
| Category: Oncology | ||||||
| 05/22/2018 | Janssen Biotech, Inc. | Erleada (Drug), ZYTIGA, DARZALEX | Food and Beverage | In-kind items and services | $10.99 | General |
| Category: Oncology | ||||||
| 04/19/2018 | Celgene Corporation | Revlimid (Drug) | Food and Beverage | In-kind items and services | $62.05 | General |
| Category: Hematology / Oncology | ||||||
| 03/19/2018 | Sysmex Inostics Inc | — | Food and Beverage | Cash or cash equivalent | $19.35 | General |
| 02/28/2018 | Janssen Biotech, Inc. | ZYTIGA (Drug), YONDELIS, DARZALEX | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: Oncology | ||||||
| 02/06/2018 | TESARO, Inc. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $88.36 | General |
| Category: ONCOLOGY | ||||||
| 02/06/2018 | Janssen Biotech, Inc. | ZYTIGA (Drug), DARZALEX, YONDELIS | Food and Beverage | In-kind items and services | $12.34 | General |
| Category: Oncology | ||||||
| 12/19/2017 | Lexicon Pharmaceuticals, Inc. | Xermelo (Drug) | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: Carcinoid Syndrome Diarrhea | ||||||
| 12/18/2017 | Bayer HealthCare Pharmaceuticals Inc. | Aliqopa (Drug) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: Oncology | ||||||
| 12/12/2017 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $14.89 | General |
| Category: Oncology | ||||||
| 12/06/2017 | Janssen Biotech, Inc. | DARZALEX (Biological), IMBRUVICA | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: Oncology | ||||||
| 12/05/2017 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: Oncology | ||||||
| 11/30/2017 | PFIZER INC. | IBRANCE (Drug) | Food and Beverage | In-kind items and services | $25.52 | General |
| Category: ONCOLOGY | ||||||
| 11/22/2017 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: ONCOLOGY | ||||||
| 11/21/2017 | Clovis Oncology, Inc. | Rubraca (Drug) | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: Oncology | ||||||
About Dr. James Welsh, M.D
Dr. James Welsh, M.D is a Hematology & Oncology healthcare provider based in Rock Hill, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1033138359.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Welsh, M.D has received a total of $2,483 in payments from pharmaceutical and medical device companies, with $13.45 received in 2021. These payments were reported across 107 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($2,483).
Practice Information
- Specialty Hematology & Oncology
- Location Rock Hill, SC
- Active Since 07/18/2006
- Last Updated 10/23/2007
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1033138359
Products in Payments
- TECENTRIQ (Biological) $223.47
- Kyprolis (Biological) $140.28
- ZYTIGA (Drug) $138.01
- KEYTRUDA (Biological) $111.08
- Cabometyx (Drug) $94.48
- Lonsurf (Drug) $91.10
- GILOTRIF (Drug) $89.56
- ZEJULA (Drug) $88.36
- Zydelig (Drug) $79.44
- EMPLICITI (Biological) $74.40
- Revlimid (Drug) $72.85
- Venclexta (Drug) $69.39
- LIBTAYO (Drug) $66.35
- IMBRUVICA (Drug) $58.31
- OPDIVO (Biological) $45.54
- Perjeta (Biological) $45.26
- DARZALEX (Biological) $42.84
- Vitrakvi (Drug) $42.76
- IMFINZI (Drug) $41.14
- IBRANCE (Drug) $38.17
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.